neoadjuvant immunotherapy
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
September, 2024
September 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« Aug
neoadjuvant immunotherapy
Sep 24, 2024, 11:40 |
Blog
Neil D. Gross: Neoadjuvant immunotherapy for advanced, resectable cutaneous squamous cell carcinoma
Neil D. Gross, The Director of Clinical Research in the Department of Head and Neck…
Sep 20, 2024, 08:16 |
Blog
Yakup Ergün: Nivolumab/Relatlimab or Nivolumab/Ipilimumab in TNBC
Yakup Ergün, Medical Oncologist at Antalya City Hospital, shared on X: "Neoadjuvant nivolumab/relatlimab or nivolumab/ipilimumab in…
Sep 15, 2024, 23:34 |
Insight
Insights from ESMO24 Day 2
The ESMO Congress 2024 is ongoing in Barcelona, from September 13 to 17, 2024, at…
Aug 26, 2024, 21:39 |
Blog
Article of the day suggested by the Immune Oncology Research Institute
Immune Oncology Research Institute made the following post on LinkedIn: "Article of the day suggested…
Aug 10, 2024, 09:08 |
Societies
12 Posts Not To Miss From Day 2 of ASCOBT24!
This Year the ASCO Breakthrough (ASCOBT24) is being held in Yokohama, Japan from 8th to…
Jul 17, 2024, 21:50 |
Blog
Ivan R. Gonzalez: Lung cancer effectiveness of immunotherapy in early stage
Ivan R. Gonzalez, Medical Oncologist at Comprehensive Oncology Center, Hospital Angeles Puebla, shared a post…
Jul 16, 2024, 05:54 |
Blog
Unprecedented level of scientific discourse at INNOVATE
Hussein Tawbi, Professor at The University of Texas MD Anderson Cancer Center, shared a post…
Jul 2, 2024, 02:01 |
Blog
Sergio Cifuentes Canaval: Exciting Advances in Immunotherapy for Colon Cancer
Sergio Cifuentes Canaval, Cancer Research Project Manager at CENEIT Mexico, shared on LinkedIn: “Exciting Advances…
Jun 22, 2024, 11:24 |
Blog
Neoadjuvant immunotherapy and SBRT in HCC
Matthias Guckenberger, Radiation Oncologist at University Hospital Zurich, shared a post on X: "Neoadjuvant immunotherapy and…
Jun 17, 2024, 04:08 |
Insight
Sergio Cifuentes: Key Changes to My Oncology Practice from ASCO2024
Sergio Cifuentes, Cancer Research Project Manager at CENEIT México, shared a post on X: "My…
Jun 12, 2024, 17:27 |
Blog
Winette van der Graaf: Two papers in the New England Journal of Medicine in one week
Winette van der Graaf shared a post on their LinkedIn: ''Extremely proud and grateful for…
Jun 10, 2024, 03:19 |
Blog
Myriam Chalabi: What a week it has been for neoadjuvant immunotherapy
Myriam Chalabi, Medical Oncologist and Cancer Immunotherapy researcher at Netherlands Cancer Institute, shared a post…
Jun 7, 2024, 14:08 |
Blog
Mark Lewis: Myriam Chalabi reporting the NICHE-2 trial in NEJM
Mark Lewis shared on X: . "TLC: don't…
Jun 7, 2024, 08:23 |
Blog
Myriam Chalabi: The results of the NICHE-2 study now published in NEJM
Myriam Chalabi, Medical Oncologist and Cancer Immunotherapy researcher at Antoni van Leeuwenhoek, shared a post…
Jun 6, 2024, 06:30 |
Blog
Ahmad Tarhini: Chatting with Patrick Hwu about the latest advances in melanoma management
Ahmad Tarhini, Director, Cutaneous Clinical and Translational Research at Moffitt Cancer Center and Research Institute,…
May 25, 2024, 11:14 |
Blog
Angelo Pirozzi: Comprehensive review from Lorenzo Gervaso about Rationale of neoadjuvant immunotherapy in GI malignancies
Angelo Pirozzi, Medical Oncology Fellow at Humanitas University and Research Fellow at Mayo Clinic (Phoenix),…
May 16, 2024, 10:23 |
Insight
News and Views from Christine Lovly and Misty Dawn Shields - Nature Medicine
Nature Medicine shared on X: “Refining neoadjuvant immunotherapy for resectable Non- Small Cell Lung Cancer…
May 2, 2024, 15:25 |
Blog
Tanja Obradovic: Interesting updates will be coming on ASCO 2024
Tanja Obradovic, Vice President of Oncology Scientific Affairs at ICON, shared on LinkedIn: "ASCO 2024 is almost…
Mar 17, 2024, 19:28 |
Blog
The first edition of the I.N.N.O.V.A.T.E congress will be held in Naples on July 11th and 12th, 2024 - 3P Solution
3P Solution shared a post on LinkedIn: "Great news coming up! We are organizing the…
Jan 27, 2024, 07:20 |
Blog
Richard Scolyer: Still no recurrence of my supposedly incurable glioblastoma!
Richard Scolyer, CoMedical Director at Melanoma Institute Australia and Surgical Pathologist at Royal Prince Alfred…
All:
20
Posts:
1 - 100
Jeff Bridges and Lymphoma: How He Went Against, How He Survived, and More
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 5
Familial Adenomatous Polyposis: Alarming Symptoms, Causes, Types, Diagnosis and Treatment
OncoDaily Party Barcelona
Ben Stiller and Prostate Cancer: How He Went Against, How He Survived, and More
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube